ATACseq: ATAC epigenome profiling Analytic Validation (Stanford)
BRD ID: 3104
Tier: SOP
Source: CIMAC-CIDC Network
Number of times downloaded: 368
Description
This assay analytical validation and performance report describes the methods used to validate the assay for transposase-accessible chromatin (ATAC) epigenome profiling using GM12878 cell line samples and presents data supporting the reported accuracy, inter- and intra-assay precision, analytical sensitivity and specificity, reference interval, and turnaround time. It is used by the Cancer Immune Monitoring and Analysis Center (CIMAC) at Stanford University. It is a product of the Cancer Immune Monitoring and Analysis Centers and Cancer Immunologic Data Center Network (CIMAC-CIDC Network; https://dctd.cancer.gov/research/networks/precision-medicine-oncology/cimac-cidc).
Biospecimens
CellLymph Node
Diagnoses
NeoplasticLymphoma
Topics
Platform-specific Methodology